UK: In the age of AMR, does a nationalised drug company make sense? The case for and against
A UK economist has come out saying that pharma companies are dragging their heels in the fight against superbugs and the only resolution would be creating a state-run drug company. Could he be right, or is international support and funding for a competitive marketplace the best solution to developing new lifesaving antibiotics? The editorial team put forward the arguments for and against a national drug company.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!